glp-1 bulimia Experts express alarm that RAs may trigger or worsen eating disorders. But is there any role they might play in binge eating disorder? And how can clinicians protect patients from risk? GLP-1 and Eating Disorders: Risks

Heintz-Buschart et al., 2018

With copays for most services, the MHBP Standard Option will help make your out-of-pocket expenses more predictable

Benefits of GLP-1 Microdosing Improved Tolerability Patients who discontinued GLP-1 medications due to side effects often find microdosing dramatically more tolerable enabling them to experience incretin benefits without the nausea that derailed their prior attempts

Eiyama, A

A recent survey from the North American Neuro-Ophthalmology Society (NANOS) recently demonstrated that the median wait time to receive care for new patients, many of whom present with acute concern, is 6 weeks [1]